Profil
Dr. Melanie Chin is a VP-Clinical Development & Head-Medical Affairs at Disc Medicine, Inc. Dr. Chin was previously employed as a Vice President-Product Strategy by Reata Pharmaceuticals, Inc. She received her graduate degree from North Carolina State University and a doctorate degree from Massachusetts Institute of Technology.
Postes actifs de Melanie Chin
| Sociétés | Poste | Début |
|---|---|---|
| DISC MEDICINE, INC. | Directeur Technique/Scientifique/R&D | 01/10/2022 |
Anciens postes connus de Melanie Chin
| Sociétés | Poste | Fin |
|---|---|---|
| REATA PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formation de Melanie Chin
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Reata Pharmaceuticals, Inc.
Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics which regulates cellular metabolism and inflammation in serious neurologic diseases | Health Technology |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
North Carolina State University
North Carolina State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Disc Medicine, Inc.
Disc Medicine, Inc. BiotechnologyHealth Technology Develops therapies addressing red blood cell production in hematologic diseases | Health Technology |
















